Hsiri Therapeutics

Developing therapies for drug-resistant bacterial and fungal infections

placeKing Of Prussia, Pennsylvania, United States calendar_todayFounded 2012 groups7 employees language hsiritherapeutics.com

Innovation

5 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 101 times.

YearFilings
20171
20181
20191
20202
20212
20224
20232
20242
20252
20261

Investor mix

2 investors on record; lead investors include BioAdvance.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon